Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.
about
Susceptibilities of anaerobic bacteria to cefoperazone and other antibioticsVariation in susceptibility patterns of species within the Bacteroides fragilis group.Practical anaerobic broth-disk elution susceptibility test.Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.Typing of Clostridium difficile causing diarrhoea in an orthopaedic wardComparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteriaReview of methods for susceptibility testing of anaerobes.Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics.In vitro susceptibilities of suspected periodontopathic anaerobes as determined by membrane transfer assay.Treatment of Clostridium difficile-associated disease with teicoplanin.Effect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin.N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteriaIn vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related speciesDifferences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance.In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.Bacteroides fragilis resistance to clindamycin in vitro.Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.Susceptibility testing of anaerobic bacteria: myth, magic, or method?Factors affecting antimicrobial susceptibility of Fusobacterium species.Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.Eubacterium lentum ATCC 43055, a new reference strain for quality control of anaerobic susceptibility tests.Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.Comparison of anaerobic susceptibility results obtained by two methods of inoculum preparationEffect of L-cysteine on the activity of penicillin antibiotics against Clostridium difficile.Transferable plasmid-linked chloramphenicol acetyltransferase conferring high-level resistance in Bacteroides uniformis.Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteriaIn vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin.In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.Macrolide-lincosamide-streptogramin resistance patterns in Clostridium perfringens from animals.Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.Tetracycline-inducible transfer of tetracycline resistance in Bacteroides fragilis in the absence of detectable plasmid DNA.Investigation of an outbreak of antibiotic-associated colitis by various typing methods.Vaspar broth-disk procedure for antibiotic susceptibility testing of anaerobic bacteria.Susceptibility testing of clinically isolated anaerobic bacteria by an agar dilution technique.Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.In vitro activity of mecillinam against anaerobic bacteria.
P2860
Q24628829-4E2249EF-194C-4E1D-B23C-FA0A96DAFA5AQ33727442-3196CD1D-E2A0-4B18-B537-A05B5422FE7FQ33728043-F464D900-82D7-477D-90AE-A9F6E05FDF11Q33730790-90487107-C904-47D2-AACF-7778877FBA4CQ33840098-6F454D15-2536-4152-8EFD-9A04A254FE42Q34167712-2BAF0473-D9AA-4A57-BFF7-53394EC904E3Q35212671-34CF787B-CA65-4F33-A7CA-8C5D0F55A667Q35252670-0990298F-0F56-4782-AED1-2670B874461CQ35563086-99BEDBEF-4594-4D3D-B224-339235776514Q35566657-214BAF38-81FE-417B-BFC6-3C3BCC4D649EQ35668902-3B4C05FD-C03D-4BD6-B63B-8952CE4B9FB5Q35673370-94227EF8-C90A-47C2-8DD4-52F80692D3CFQ35713632-BE3A8F2E-7FC9-4958-95BC-C5E02F66FB5EQ35718303-D8771818-CEFE-4EBA-BEC3-A052761A0FB4Q35739778-DA0DCD8B-1904-4BD3-BD95-20C0A16470B6Q35761119-43428385-319D-4777-B2E1-A38CA1243770Q35761288-04B068B6-2A6C-4C85-9CC0-47EA2D85DB1BQ36638147-C0C6BC77-41DE-466E-BE87-9B193BB19E4DQ37137565-D35A13D8-2583-45E1-8F0A-B95FD0356A43Q37148075-E04A815E-1813-4EF6-824F-C180EEDE8F1CQ37158142-4BCC4981-DCB3-4978-95E1-1D2407C77358Q37191573-3FCBFB26-6EDD-4AF9-80CD-DFCCB7CCE959Q37223533-03F6EF6F-7045-47BD-98F0-19A2B001802DQ37273431-1DC8F06B-DCCD-43F7-9141-197A361C1468Q39833994-BAB28D1B-DC24-4EED-B548-6D98B48422B7Q39834127-E5FCF07F-E424-45D8-B8DE-6CDB29DE0D1EQ39834540-3ACDB73D-25B5-44D9-B09D-DC1C2CD20B05Q39834927-F2AF836C-436D-473D-AB9B-2C2CE2179EC8Q39849873-379ACDBF-5F16-4629-A84F-005C2391E78BQ39849921-C740302C-C855-4267-A98F-D176766B5223Q39854364-043342E4-7DB0-4261-83E1-C9FE1F59B4C2Q39854523-2915FBDF-35CE-4A17-A9E2-AD76DBC22B2AQ39854546-68D4BF83-77CA-46DE-AE57-3F2EE48E6CEBQ39856054-ECB31256-6B07-41CB-8BFC-121A81DF0730Q39983803-152202E4-F6BF-4F0E-89A3-44EEE40A145EQ40225618-58FA938F-4C9D-4D25-8C9A-701C99091908Q40281507-B965CE0C-774F-4519-AAD6-5D7CC44D9894Q40281859-A3C1D784-2049-4F66-87C9-0CBF72D375B4Q40282147-668678FB-3126-4179-BB05-21819C481A9EQ40282223-DFCCD6E8-BD68-4C52-999E-BDD7567D34A7
P2860
Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Collaborative evaluation of a ...... testing of anaerobic bacteria.
@ast
Collaborative evaluation of a ...... testing of anaerobic bacteria.
@en
type
label
Collaborative evaluation of a ...... testing of anaerobic bacteria.
@ast
Collaborative evaluation of a ...... testing of anaerobic bacteria.
@en
prefLabel
Collaborative evaluation of a ...... testing of anaerobic bacteria.
@ast
Collaborative evaluation of a ...... testing of anaerobic bacteria.
@en
P2093
P2860
P356
P1476
Collaborative evaluation of a ...... testing of anaerobic bacteria.
@en
P2093
Wilkins TD
Zabransky RJ
P2860
P304
P356
10.1128/AAC.16.4.495
P407
P577
1979-10-01T00:00:00Z